Atlas Trials

To Compare Pharmacokinetics, Efficacy, and Safety of CT-P17 With Humira in Patients With Moderate to Severe Chronic Plaque Psoriasis

Clinical trial NCT05495568 · COMPLETED

Trial details

NCT number
NCT05495568
Sponsor
Celltrion
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Moderate to Severe Chronic Plaque Psoriasis
Start date
2022-11-07
Primary completion
2023-08-14
Enrollment
367

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.